HIV/STI Clinical Track

The HIV/STI Clinical Track is designed to provide focused experiences in HIV/AIDS clinical management, HIV prevention, HIV research, and STI subspecialty care. Fellows have the opportunity to expand their inpatient/outpatient clinical experiences at UTSW/Parkland, rotate through our PrEP/STI clinics, and rotate through the Dallas County Jail HIV clinic. In addition, fellows are provided research mentors in the field of HIV/STIs to help develop and complete a project in an area of interest. Specific components of the track can be modified to fit each fellow’s individual career aspirations and needs.


The curriculum aims to promote excellence in the following areas:

  1. Inpatient care of advanced HIV including opportunistic infections, immune reconstitution syndrome, and multidrug resistant HIV
  2. Outpatient care of HIV including ART initiation, management of toxicities and intolerances, and resistance
  3. Comprehensive primary care in those with stable HIV
  4. HIV prevention strategies including PrEP and targeted counseling
  5. STI treatment and prevention

Available Activities

  • Additional time on the inpatient HIV consultation service at Parkland
  • Elective time at the PrEP/STI clinic
  • Elective time in high-risk OB and perinatal HIV clinic
  • Elective time at the Dallas County Jail HIV clinic
  • Opportunity to lecture medical students, Physician Assistant students, residents, and fellows on topics related to HIV/STIs
  • Abstract submissions to conferences such as CROI, ACT-HIV, and IDweek
  • Mentor-guided research to include case series or case reports, quality improvement projects, or systematic review articles
  • Opportunities to work on community initiatives aimed at reducing HIV and STI incidence such as HIV Fast Track Cities


Fellows can take advantage of UTSW/Parkland’s extensive resources in HIV/STI prevention, treatment, and research. Weekly HIV and General ID didactic series given by faculty. A faculty research mentor will be identified, and fellows are strongly encouraged to conduct clinical or translational research and disseminate this work at a regional or national HIV meetings.